Polo-like kinase 3, hypoxic responses, and tumorigenesis

References

• Kaelin WG, Jr, Ratcliffe PJ. Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008;30:393-402. doi:10.1016/j.molcel.2008.04.009. PMID:18498744
   PubMed Web of Science ®Google Scholar
• Bruick RK. Oxygen sensing in the hypoxic response pathway: regulation of the hypoxia-inducible transcription factor. Genes Dev. 2003;17:2614-23. doi:10.1101/gad.1145503. PMID:14597660
   PubMed Web of Science ®Google Scholar
• Semenza GL. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol. 1999;15:551-78. doi:10.1146/annurev.cellbio.15.1.551. PMID:10611972
   PubMed Web of Science ®Google Scholar
• Flugel D, Gorlach A, Michiels C, Kietzmann T. Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner. Mol Cell Biol. 2007;27:3253-65. doi:10.1128/MCB.00015-07. PMID:17325032
   PubMed Web of Science ®Google Scholar
• Richard DE, Berra E, Gothie E, Roux D, Pouyssegur J. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1alpha (HIF-1alpha) and enhance the transcriptional activity of HIF-1. J Biol Chem. 1999;274:32631-7. doi:10.1074/jbc.274.46.32631. PMID:10551817
   PubMed Web of Science ®Google Scholar
• Mylonis I, Chachami G, Samiotaki M, Panayotou G, Paraskeva E, Kalousi A, Georgatsou E, Bonanou S, Simos G. Identification of MAPK phosphorylation sites and their role in the localization and activity of hypoxia-inducible factor-1alpha. J Biol Chem. 2006;281:33095-106. doi:10.1074/jbc.M605058200. PMID:16954218
   PubMed Web of Science ®Google Scholar
• Mylonis I, Chachami G, Paraskeva E, Simos G. Atypical CRM1-dependent nuclear export signal mediates regulation of hypoxia-inducible factor-1alpha by MAPK. J Biol Chem. 2008;283:27620-7. doi:10.1074/jbc.M803081200. PMID:18687685
   PubMed Web of Science ®Google Scholar
• Xu D, Yao Y, Lu L, Costa M, Dai W. Plk3 functions as an essential component of the hypoxia regulatory pathway by direct phosphorylation of HIF-1alpha. J Biol Chem. 2010;285:38944-50. doi:10.1074/jbc.M110.160325. PMID:20889502
   PubMed Web of Science ®Google Scholar
• Yang Y, Bai J, Shen R, Brown SA, Komissarova E, Huang Y, Jiang N, Alberts GF, Costa M, Lu L, et al. Polo-like kinase 3 functions as a tumor suppressor and is a negative regulator of hypoxia-inducible factor-1 alpha under hypoxic conditions. Cancer Res. 2008;68:4077-85. doi:10.1158/0008-5472.CAN-07-6182. PMID:18519666
   PubMed Web of Science ®Google Scholar
• Harris AL. Hypoxia–a key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2:38-47. doi:10.1038/nrc704. PMID:11902584
   PubMed Web of Science ®Google Scholar
• Semenza GL. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression. Crit Rev Biochem Mol Biol. 2000;35:71-103. doi:10.1080/10409230091169186. PMID:10821478
   PubMed Web of Science ®Google Scholar
• Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3:721-32. doi:10.1038/nrc1187. PMID:13130303
   PubMed Web of Science ®Google Scholar
• Semenza GL. Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy. Trends Pharmacol Sci. 2012;33:207-14. doi:10.1016/j.tips.2012.01.005. PMID:22398146
   PubMed Web of Science ®Google Scholar
• Archambault V, Glover DM. Polo-like kinases: conservation and divergence in their functions and regulation. Nat Rev Mol Cell Biol. 2009;10:265-75. doi:10.1038/nrm2653. PMID:19305416
   PubMed Web of Science ®Google Scholar
• Xu D, Wang Q, Jiang Y, Zhang Y, Vega-Saenzdemiera E, Osman I, Dai W. Roles of Polo-like kinase 3 in suppressing tumor angiogenesis. Exp Hematol Oncol. 2012;1:5. doi:10.1186/2162-3619-1-5. PMID:23210979
   PubMedGoogle Scholar
• Zitouni S, Nabais C, Jana SC, Guerrero A, Bettencourt-Dias M. Polo-like kinases: structural variations lead to multiple functions. Nat Rev Mol Cell Biol. 2014;15:433-52. doi:10.1038/nrm3819. PMID:24954208
   PubMed Web of Science ®Google Scholar
• de Carcer G, Manning G, Malumbres M. From Plk1 to Plk5: functional evolution of polo-like kinases. Cell Cycle. 2011;10:2255-62. doi:10.4161/cc.10.14.16494. PMID:21654194
   PubMed Web of Science ®Google Scholar
• Andrysik Z, Bernstein WZ, Deng L, Myer DL, Li YQ, Tischfield JA, Stambrook PJ, Bahassi el M. The novel mouse Polo-like kinase 5 responds to DNA damage and localizes in the nucleolus. Nucleic Acids Res. 2010;38:2931-43. doi:10.1093/nar/gkq011. PMID:20100802
   PubMed Web of Science ®Google Scholar
• de Carcer G, Escobar B, Higuero AM, Garcia L, Anson A, Perez G, Mollejo M, Manning G, Melendez B, Abad-Rodriguez J, et al. Plk5, a polo box domain-only protein with specific roles in neuron differentiation and glioblastoma suppression. Mol Cell Biol. 2011;31:1225-39. doi:10.1128/MCB.00607-10. PMID:21245385
   PubMed Web of Science ®Google Scholar
• Eckerdt F, Yuan J, Strebhardt K. Polo-like kinases and oncogenesis. Oncogene. 2005;24:267-76. doi:10.1038/sj.onc.1208273. PMID:15640842
   PubMed Web of Science ®Google Scholar
• Helmke C, Becker S, Strebhardt K. The role of Plk3 in oncogenesis. Oncogene. 2016;35:135-47. doi:10.1038/onc.2015.105. PMID:25915845
   PubMed Web of Science ®Google Scholar
• Liu X. Targeting Polo-Like Kinases: a promising therapeutic approach for cancer treatment. Transl Oncol. 2015;8:185-95. doi:10.1016/j.tranon.2015.03.010. PMID:26055176
   PubMed Web of Science ®Google Scholar
• Zimmerman WC, Erikson RL. Polo-like kinase 3 is required for entry into S phase. Proc Natl Acad Sci U S A. 2007;104:1847-52. doi:10.1073/pnas.0610856104. PMID:17264206
   PubMed Web of Science ®Google Scholar
• Zimmerman WC, Erikson RL. Finding Plk3. Cell Cycle. 2007;6:1314-8. doi:10.4161/cc.6.11.4275. PMID:17568195
   PubMed Web of Science ®Google Scholar
• Bahassi el M, Conn CW, Myer DL, Hennigan RF, McGowan CH, Sanchez Y, Stambrook PJ. Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways. Oncogene. 2002;21:6633-40. doi:10.1038/sj.onc.1205850. PMID:12242661
   PubMed Web of Science ®Google Scholar
• Xie S, Wu H, Wang Q, Kunicki J, Thomas RO, Hollingsworth RE, Cogswell J, Dai W. Genotoxic stress-induced activation of Plk3 is partly mediated by Chk2. Cell Cycle. 2002;1:424-9. doi:10.4161/cc.1.6.271. PMID:12548019
   PubMed Web of Science ®Google Scholar
• Wang L, Gao J, Dai W, Lu L. Activation of Polo-like kinase 3 by hypoxic stresses. J Biol Chem. 2008;283:25928-35. doi:10.1074/jbc.M801326200. PMID:18650425
   PubMed Web of Science ®Google Scholar
• Wang L, Payton R, Dai W, Lu L. Hyperosmotic stress-induced ATF-2 activation through Polo-like kinase 3 in human corneal epithelial cells. J Biol Chem. 2011;286:1951-8. doi:10.1074/jbc.M110.166009. PMID:21098032
   PubMed Web of Science ®Google Scholar
• Myer DL, Robbins SB, Yin M, Boivin GP, Liu Y, Greis KD, Bahassi el M, Stambrook PJ. Absence of polo-like kinase 3 in mice stabilizes Cdc25A after DNA damage but is not sufficient to produce tumors. Mutat Res. 2011;714:1-10. doi:10.1016/j.mrfmmm.2011.02.006. PMID:21376736
   PubMed Web of Science ®Google Scholar
• Hudson JW, Kozarova A, Cheung P, Macmillan JC, Swallow CJ, Cross JC, Dennis JW. Late mitotic failure in mice lacking Sak, a polo-like kinase. Curr Biol. 2001;11:441-6. doi:10.1016/S0960-9822(01)00117-8. PMID:11301255
   PubMed Web of Science ®Google Scholar
• Lu LY, Wood JL, Minter-Dykhouse K, Ye L, Saunders TL, Yu X, Chen J. Polo-like kinase 1 is essential for early embryonic development and tumor suppression. Mol Cell Biol. 2008;28:6870-6. doi:10.1128/MCB.00392-08. PMID:18794363
   PubMed Web of Science ®Google Scholar
• Ouyang B, Pan H, Lu L, Li J, Stambrook P, Li B, Dai W. Human Prk is a conserved protein serine/threonine kinase involved in regulating M phase functions. J Biol Chem. 1997;272:28646-51. doi:10.1074/jbc.272.45.28646. PMID:9353331
   PubMed Web of Science ®Google Scholar
• Lee KS, Grenfell TZ, Yarm FR, Erikson RL. Mutation of the polo-box disrupts localization and mitotic functions of the mammalian polo kinase Plk. Proc Natl Acad Sci U S A. 1998;95:9301-6. doi:10.1073/pnas.95.16.9301. PMID:9689075
   PubMed Web of Science ®Google Scholar
• Li B, Ouyang B, Pan H, Reissmann PT, Slamon DJ, Arceci R, Lu L, Dai W. Prk, a cytokine-inducible human protein serine/threonine kinase whose expression appears to be down-regulated in lung carcinomas. J Biol Chem. 1996;271:19402-8. doi:10.1074/jbc.271.32.19402. PMID:8702627
   PubMed Web of Science ®Google Scholar
• Wiest J, Clark AM, Dai W. Intron/exon organization and polymorphisms of the PLK3/PRK gene in human lung carcinoma cell lines. Genes Chromosomes Cancer. 2001;32:384-9. doi:10.1002/gcc.1204. PMID:11746980
   PubMed Web of Science ®Google Scholar
• Flugel D, Gorlach A, Kietzmann T. GSK-3beta regulates cell growth, migration, and angiogenesis via Fbw7 and USP28-dependent degradation of HIF-1alpha. Blood. 2012;119:1292-301. doi:10.1182/blood-2011-08-375014. PMID:22144179
   PubMed Web of Science ®Google Scholar
• Whitman M, Downes CP, Keeler M, Keller T, Cantley L. Type I phosphatidylinositol kinase makes a novel inositol phospholipid, phosphatidylinositol-3-phosphate. Nature. 1988;332:644-6. doi:10.1038/332644a0. PMID:2833705
   PubMed Web of Science ®Google Scholar
• Liu P, Cheng H, Roberts TM, Zhao JJ. Targeting the phosphoinositide 3-kinase pathway in cancer. Nat Rev Drug Discov. 2009;8:627-44. doi:10.1038/nrd2926. PMID:19644473
   PubMed Web of Science ®Google Scholar
• Hamada K, Sasaki T, Koni PA, Natsui M, Kishimoto H, Sasaki J, Yajima N, Horie Y, Hasegawa G, Naito M, et al. The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis. Genes Dev. 2005;19:2054-65. doi:10.1101/gad.1308805. PMID:16107612
   PubMed Web of Science ®Google Scholar
• Yee Koh M, Spivak-Kroizman TR, Powis G. HIF-1 regulation: not so easy come, easy go. Trends Biochem Sci. 2008;33:526-34. doi:10.1016/j.tibs.2008.08.002. PMID:18809331
   PubMed Web of Science ®Google Scholar
• Jiang BH, Zheng JZ, Aoki M, Vogt PK. Phosphatidylinositol 3-kinase signaling mediates angiogenesis and expression of vascular endothelial growth factor in endothelial cells. Proc Natl Acad Sci U S A. 2000;97:1749-53. doi:10.1073/pnas.040560897. PMID:10677529
   PubMed Web of Science ®Google Scholar
• Gericke A, Munson M, Ross AH. Regulation of the PTEN phosphatase. Gene. 2006;374:1-9. doi:10.1016/j.gene.2006.02.024. PMID:16675164
   PubMed Web of Science ®Google Scholar
• Xu D, Yao Y, Jiang X, Lu L, Dai W. Regulation of PTEN stability and activity by Plk3. J Biol Chem. 2010;285:39935-42. doi:10.1074/jbc.M110.166462. PMID:20940307
   PubMed Web of Science ®Google Scholar
• Miller SJ, Lou DY, Seldin DC, Lane WS, Neel BG. Direct identification of PTEN phosphorylation sites. FEBS Lett. 2002;528:145-53. doi:10.1016/S0014-5793(02)03274-X. PMID:12297295
   PubMed Web of Science ®Google Scholar
• Torres J, Pulido R. The tumor suppressor PTEN is phosphorylated by the protein kinase CK2 at its C terminus. Implications for PTEN stability to proteasome-mediated degradation. J Biol Chem. 2001;276:993-8. doi:10.1074/jbc.M009134200. PMID:11035045
   PubMed Web of Science ®Google Scholar
• Al-Khouri AM, Ma Y, Togo SH, Williams S, Mustelin T. Cooperative phosphorylation of the tumor suppressor phosphatase and tensin homologue (PTEN) by casein kinases and glycogen synthase kinase 3beta. J Biol Chem. 2005;280:35195-202. doi:10.1074/jbc.M503045200. PMID:16107342
   PubMed Web of Science ®Google Scholar
• Mehenni H, Lin-Marq N, Buchet-Poyau K, Reymond A, Collart MA, Picard D, Antonarakis SE. LKB1 interacts with and phosphorylates PTEN: a functional link between two proteins involved in cancer predisposing syndromes. Hum Mol Genet. 2005;14:2209-19. doi:10.1093/hmg/ddi225. PMID:15987703
   PubMed Web of Science ®Google Scholar
• Valiente M, Andres-Pons A, Gomar B, Torres J, Gil A, Tapparel C, Antonarakis SE, Pulido R. Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases. J Biol Chem. 2005;280:28936-43. doi:10.1074/jbc.M504761200. PMID:15951562
   PubMed Web of Science ®Google Scholar
• Lu Y, Yu Q, Liu JH, Zhang J, Wang H, Koul D, McMurray JS, Fang X, Yung WK, Siminovitch KA, et al. Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades. J Biol Chem. 2003;278:40057-66. doi:10.1074/jbc.M303621200. PMID:12869565
   PubMed Web of Science ®Google Scholar
• Adey NB, Huang L, Ormonde PA, Baumgard ML, Pero R, Byreddy DV, Tavtigian SV, Bartel PL. Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding. Cancer Res. 2000;60:35-7. PMID:10646847
   PubMed Web of Science ®Google Scholar
• Vazquez F, Grossman SR, Takahashi Y, Rokas MV, Nakamura N, Sellers WR. Phosphorylation of the PTEN tail acts as an inhibitory switch by preventing its recruitment into a protein complex. J Biol Chem. 2001;276:48627-30. doi:10.1074/jbc.C100556200. PMID:11707428
   PubMed Web of Science ®Google Scholar
• Tolkacheva T, Boddapati M, Sanfiz A, Tsuchida K, Kimmelman AC, Chan AM. Regulation of PTEN binding to MAGI-2 by two putative phosphorylation sites at threonine 382 and 383. Cancer Res. 2001;61:4985-9. PMID:11431330
   PubMed Web of Science ®Google Scholar
• Odriozola L, Singh G, Hoang T, Chan AM. Regulation of PTEN activity by its carboxyl-terminal autoinhibitory domain. J Biol Chem. 2007;282:23306-15. doi:10.1074/jbc.M611240200. PMID:17565999
   PubMed Web of Science ®Google Scholar
• Rahdar M, Inoue T, Meyer T, Zhang J, Vazquez F, Devreotes PN. A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN. Proc Natl Acad Sci U S A. 2009;106:480-5. doi:10.1073/pnas.0811212106. PMID:19114656
   PubMed Web of Science ®Google Scholar
• Li C, Park S, Zhang X, Dai W, Xu D. Mutual regulation between Polo-like Kinase 3 and SIAH2 E3 ubiquitin ligase defines a regulatory network that fine-tunes the cellular response to hypoxia and nickel. J Biol Chem. 2017;292:11431-44. doi:10.1074/jbc.M116.767178. PMID:28515325
   PubMed Web of Science ®Google Scholar
• House CM, Frew IJ, Huang HL, Wiche G, Traficante N, Nice E, Catimel B, Bowtell DD. A binding motif for Siah ubiquitin ligase. Proc Natl Acad Sci U S A. 2003;100:3101-6. doi:10.1073/pnas.0534783100. PMID:12626763
   PubMed Web of Science ®Google Scholar
• House CM, Hancock NC, Moller A, Cromer BA, Fedorov V, Bowtell DD, Parker MW, Polekhina G. Elucidation of the substrate binding site of Siah ubiquitin ligase. Structure. 2006;14:695-701. doi:10.1016/j.str.2005.12.013. PMID:16615911
   PubMed Web of Science ®Google Scholar
• Nakayama K, Qi J, Ronai Z. The ubiquitin ligase Siah2 and the hypoxia response. Mol Cancer Res. 2009;7:443-51. doi:10.1158/1541-7786.MCR-08-0458. PMID:19372575
   PubMed Web of Science ®Google Scholar
• Qi J, Nakayama K, Gaitonde S, Goydos JS, Krajewski S, Eroshkin A, Bar-Sagi D, Bowtell D, Ronai Z. The ubiquitin ligase Siah2 regulates tumorigenesis and metastasis by HIF-dependent and -independent pathways. Proc Natl Acad Sci U S A. 2008;105:16713-8. doi:10.1073/pnas.0804063105. PMID:18946040
   PubMed Web of Science ®Google Scholar
• Popov N, Wanzel M, Madiredjo M, Zhang D, Beijersbergen R, Bernards R, Moll R, Elledge SJ, Eilers M. The ubiquitin-specific protease USP28 is required for MYC stability. Nat Cell Biol. 2007;9:765-74. doi:10.1038/ncb1601. PMID:17558397
   PubMed Web of Science ®Google Scholar
• Zhang D, Zaugg K, Mak TW, Elledge SJ. A role for the deubiquitinating enzyme USP28 in control of the DNA-damage response. Cell. 2006;126:529-42. doi:10.1016/j.cell.2006.06.039. PMID:16901786
   PubMed Web of Science ®Google Scholar
• Li Q, Kluz T, Sun H, Costa M. Mechanisms of c-myc degradation by nickel compounds and hypoxia. PloS One. 2009;4:e8531. doi:10.1371/journal.pone.0008531. PMID:20046830
   PubMed Web of Science ®Google Scholar
• Kozma SC, Thomas G. Regulation of cell size in growth, development and human disease: PI3K, PKB and S6K. Bioessays. 2002;24:65-71. doi:10.1002/bies.10031. PMID:11782951
   PubMed Web of Science ®Google Scholar
• Wong CS, Moller A. Siah: a promising anticancer target. Cancer Res. 2013;73:2400-6. doi:10.1158/0008-5472.CAN-12-4348. PMID:23455005
   PubMed Web of Science ®Google Scholar
• Qi J, Kim H, Scortegagna M, Ronai ZA. Regulators and effectors of Siah ubiquitin ligases. Cell Biochem Biophys. 2013;67:15-24. doi:10.1007/s12013-013-9636-2. PMID:23700162
   PubMed Web of Science ®Google Scholar